|
|
||||||||
Recombinant proteins containing the B domain of dengue virus serotypes 1-4 fused to the maltose binding protein (MBP) of Escherichia coli were evaluated individually and as a tetravalent vaccine candidate in mice. Sera from mice immunized with monovalent DEN-MBP recombinant protein vaccines developed high titers of serotype homologous antibody in the enzyme-linked immunosorbent assay and the plaque-reduction neutralization test. Cross-reactive antibody titers were either several dilutions lower or not detectable. Sera from mice immunized with the tetravalent DEN subunit vaccine neutralized all 4 DEN viruses in the plaque-reduction neutralization test. The neutralizing antibody titers to each individual serotype were significantly greater than any cross-reactive neutralizing antibody titers induced by the monovalent vaccines, providing evidence that the tetravalent DEN recombinant subunit vaccine produced specific neutralizing antibody to all 4 serotypes of dengue virus.
This article has been cited by other articles:
![]() |
B. Etemad, G. Batra, R. Raut, S. Dahiya, S. Khanam, S. Swaminathan, and N. Khanna An Envelope Domain III-based Chimeric Antigen Produced in Pichia pastoris Elicits Neutralizing Antibodies Against All Four Dengue Virus Serotypes Am J Trop Med Hyg, September 1, 2008; 79(3): 353 - 363. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. U. RAJA, D. H. HOLMAN, D. WANG, K. RAVIPRAKASH, L. Y. JUOMPAN, S. B. DEITZ, M. LUO, J. ZHANG, K. R. PORTER, and J. Y. DONG INDUCTION OF BIVALENT IMMUNE RESPONSES BY EXPRESSION OF DENGUE VIRUS TYPE 1 AND TYPE 2 ANTIGENS FROM A SINGLE COMPLEX ADENOVIRAL VECTOR Am J Trop Med Hyg, April 1, 2007; 76(4): 743 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fernandez, D. R. Palmer, M. Simmons, P. Sun, J. Bisbing, S. McClain, S. Mani, T. Burgess, V. Gunther, and W. Sun Potential Role for Toll-Like Receptor 4 in Mediating Escherichia coli Maltose-Binding Protein Activation of Dendritic Cells Infect. Immun., March 1, 2007; 75(3): 1359 - 1363. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. KHANAM, B. ETEMAD, N. KHANNA, and S. SWAMINATHAN INDUCTION OF NEUTRALIZING ANTIBODIES SPECIFIC TO DENGUE VIRUS SEROTYPES 2 AND 4 BY A BIVALENT ANTIGEN COMPOSED OF LINKED ENVELOPE DOMAINS III OF THESE TWO SEROTYPES Am J Trop Med Hyg, February 1, 2006; 74(2): 266 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Chambers, Y. Liang, D. A. Droll, J. J. Schlesinger, A. D. Davidson, P. J. Wright, and X. Jiang Yellow Fever Virus/Dengue-2 Virus and Yellow Fever Virus/Dengue-4 Virus Chimeras: Biological Characterization, Immunogenicity, and Protection against Dengue Encephalitis in the Mouse Model J. Virol., March 15, 2003; 77(6): 3655 - 3668. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ludolfs, S. Schilling, J. Altenschmidt, and H. Schmitz Serological Differentiation of Infections with Dengue Virus Serotypes 1 to 4 by Using Recombinant Antigens J. Clin. Microbiol., November 1, 2002; 40(11): 4317 - 4320. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |